Multiply Labs
multiplylabs.comPhysical AI for biological manufacturing
Hardware & IoTroboticsbiomanufacturingadvanced-therapiesgmpphysical-aiautomationlife-sciences
About
Multiply Labs builds robotic biomanufacturing infrastructure that automates the full biologics manufacturing stack within closed, GMP-ready systems. Their robotic clusters integrate with a facility's existing validated instruments, enabling up to 100x throughput increases and 74% cost reductions. The platform includes real-time sensor monitoring and 21 CFR Part 11-compliant electronic records integrated with existing quality systems.
Problem
Current biomanufacturing infrastructure was built for small molecules and large batches and cannot meet the scale, complexity, precision, or cost demands of next-generation biological therapies.
For
Pharmaceutical and biotech manufacturers producing advanced therapies and biologics
How it works
Robotic clusters connect to a facility's existing GMP instruments in a closed, sterile environment and use imitation learning and parallel orchestration to automate every unit operation, collecting real-time data and delivering electronic records to quality systems.
Business model
unknown
Status
launched
Company
Multiply Labs
Founders
- Alice Melocchi
- Fred Parietti